Patent · US Active

Methods and compositions for determining and treating relapse in inflammatory bowel disease

US9995752B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignees

Children's Hospital Medical Center · US
WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER · DE

Inventors

Lee A. Denson · Wyoming, US
Bruce C. Trapnell · Monroe, US
Jan Däbritz · Berlin, DE

Key dates

Filing date	May 13, 2014
Grant date	Jun 12, 2018
Priority date	—
Expiry date	May 13, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/54
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Described are methods and compositions for evaluating the relapse risk n subjects having an inflammatory bowel disease (IBD). Some embodiments include selecting a treatment for an evaluated IBD relapse risk in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.